供体CYP3A5基因型影响儿童肝移植后首日他克莫司处置
该研究在67例儿童肝移植受者中评估供受体CYP3A4/5基因型、年龄和性别对他克莫司首日血药谷浓度及浓度/体重校正剂量比的影响。供体CYP3A5基因型与他克莫司首日处置显著相关(P < 0.0002),受者年龄是唯一独立相关因素(P < 0.03),6岁以下儿童代谢更快(P < 0.02)。
要点
- 供体CYP3A5基因型显著影响儿童肝移植后首日他克莫司谷浓度和浓度/体重校正剂量比。
- 受者年龄是首日他克莫司处置的独立相关因素,6岁以下儿童代谢更快。
- 供体性别可能也起作用,但多因素分析中仅受者年龄独立相关。
核心结论
- 供体CYP3A5基因型、受者年龄及程度较轻的供体性别与他克莫司移植后首日处置相关。
- 对于6岁以下且接受男性快代谢者供肝的儿童,提高他克莫司起始剂量可能使血药浓度更快达到治疗范围。
研究设计与样本
- 研究纳入67例儿童肝移植受者,其中33例男孩和34例女孩,平均年龄4.5岁。
- 评估供受体CYP3A4/5基因型、年龄和性别对他克莫司首日血药谷浓度(C0)及浓度/体重校正剂量比的影响。
主要发现
- 供体CYP3A5基因型与他克莫司首日处置显著相关(P < 0.0002)。
- 受者年龄和供体性别可能也导致他克莫司首日C0及浓度/体重校正剂量比出现显著差异。
- 一般线性模型显示仅受者年龄与他克莫司首日处置独立相关(P < 0.03)。
- 6岁以下儿童他克莫司代谢更快(P < 0.02)。
临床怎么用
- 儿童肝移植后首日他克莫司剂量调整可考虑供体CYP3A5基因型、受者年龄和供体性别。
- 对6岁以下且接受男性快代谢者供肝的患儿,可考虑提高他克莫司起始剂量以更快达到治疗范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The aim of the present study was to investigate the influence of the cytochrome P450 (CYP) 3A4/5 genotype in paediatric liver transplant recipients and donors, and the contribution of age and gender to tacrolimus disposition on the first day after transplantation. METHODS: The contribution of the CYP3A4/5 genotype in paediatric liver transplant recipients and donors to the tacrolimus blood trough concentrations (C0 ) and the tacrolimus concentration/weight-adjusted dose ratio on day 1 was evaluated in 67 liver-transplanted children: 33 boys and 34 girls, mean age 4.5 years. RESULTS: Donor CYP3A5 genotype appears to be significantly associated with tacrolimus disposition on the first day after liver transplantation (P < 0.0002). Other physiological factors, such as recipient age and donor gender may also play a role and lead to significant differences in tacrolimus C0 and tacrolimus concentration/weight-adjusted dose ratio on day 1. However, according to the general linear model, only recipient age appears to be independently associated with tacrolimus disposition on the first day after liver transplantation (P < 0.03). Indeed, there was a faster tacrolimus metabolism in children under 6 years of age (P < 0.02). CONCLUSIONS: Donor CYP3A5 genotype, recipient age and, to a lesser extent, donor gender appear to be associated with tacrolimus disposition on day 1 after transplant. This suggests that increasing the starting tacrolimus doses in paediatric patients under 6 years of age who receive a graft from a male extensive metabolizer may enhance the possibility of their tacrolimus levels reaching the therapeutic range sooner.
引用
- Calvo PL, Serpe L, Brunati A, et al. Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation. Br J Clin Pharmacol. 2017. PMID: 28044353. doi:10.1111/bcp.13219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。